And here it is, page-13

Seem the ceo and board no interested in those that stuck by them. We now just a hinderance
see on Uscom LinkedIn another post saying only few days ago bp + device get a major study validation.
report say validates bp + device as technological leader in blood pressure monitoring.
should be easy to sell millions of them if world leader product as say
wonder why company not want share to go up back above company buy back price of 5.5c
few year now but capital raising to reward shareholders was 11c
share now 1.2c and nobody in entire world interest in paying above that price